Moreover, gastrin has been demonstrated to facilitate tumor growth via paracrine and autocrine mechanisms mediated by the cholecystokinin-B receptor (CCK-BR), which has been found to be expressed in approximately 50% of GC patients (Duan et al., 2022). Here, CCKBR is linked to gastric cancer.